RSS

cell therapy

Here, Trevor Marshall, director of global engineering at Zenith Technologies, goes into detail about how integrating and automating cell therapy production with MES will help grow the personalised medicine sector and ultimately benefit patients more

Opinion

The UCL Technology Fund (UCLTF) and UK Innovation & Science Seed Fund (UKI2S), with support from Innovate UK, have invested in cell therapy company Glialign — a spin out company from UCL. more

News

Cell & Gene Therapies: A guide to single-use fluid connections more

Developer of placenta-based cell therapy products, Pluristem Therapeutics, has revealed that its PLX cells have been shown to significantly inhibit cancer cell growth in a recently published peer-reviewed article. more

News

GE Healthcare, provider of transformational medical technologies and services, has introduced the first in its VIA Thaw series, the VIA Thaw CB1000, which offers automated, dry thawing of cryo-bags to address cell therapy challenges. more

Technology

The Sartorius and Science Prize for Regenerative Medicine & Cell Therapy is focused towards scientists advancing research within the relevant fields, with the winner receiving $25,000 in prize money and being published in Science magazine more

News

GE Healthcare completes a strategic minority investment and fills a space in its cell therapy production with an acquisition. more

Technology

After President Trump’s announcement of budget cuts to US governmental scientific agencies last week, the ISCT has stated that ramifications to science, clinical care and patients in the US and internationally will be severe and harmful. more

News

A major GMP inspection has successfully concluded for apceth's production facilities. The GMP inspection was conducted by the Bavarian state authorities and the Germany regulatory agency Paul-Ehrlich-Institute more

News

Cell therapies developer Plasticell has recruited Dr. Aaron Chuang chief scientific officer (CSO). Dr. Chuang takes on responsibility for preclinical therapeutic programmes and scientific oversight of collaborations and alliances, as well as external more

News

Fibrocell Science and Intrexon have announced positive in vitro pre-clinical data for Fibrocell's lead orphan gene-therapy drug candidate for the treatment of recessive dystrophic epidermolysis bullosa. more

News

Cell Medica, a cellular immunotherapy company, has started commercial cell therapy manufacturing at its facility at the Max-Delbrück-Center of Molecular Medicine in Berlin-Buch, Germany. more

News

The companies will co-market AGTC's HAVE manufacturing method with SAFC's cGMP manufacturing capabilities. more

Home

Xuri IL-2 is a dedicated cell therapy ancillary product for the ex vivo cultivation of T-lymphocytes. Xuri IL-2’s defined level of biological activity removes the need for revalidation of each lot and strongly improves reproducibility, thereby... more

Technology